HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Burnier Selected Research

Glycosuria

1/2022Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.
6/2018Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel Burnier Research Topics

Disease

118Hypertension (High Blood Pressure)
03/2024 - 07/2000
26Chronic Renal Insufficiency
03/2023 - 01/2007
15Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 01/2006
13Heart Failure
01/2023 - 08/2003
13Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 08/2006
10Essential Hypertension
01/2019 - 01/2002
10Type 2 Diabetes Mellitus (MODY)
06/2018 - 05/2003
9Obesity
11/2020 - 09/2007
8Albuminuria
02/2024 - 01/2006
8Weight Gain
01/2021 - 02/2002
7Diabetic Nephropathies (Diabetic Nephropathy)
03/2022 - 01/2006
7Cardiomegaly (Heart Hypertrophy)
05/2012 - 06/2002
6Diabetes Mellitus
01/2023 - 07/2010
6Renal Insufficiency (Renal Failure)
01/2023 - 05/2003
6Body Weight (Weight, Body)
01/2021 - 03/2004
6Edema (Dropsy)
01/2021 - 02/2002
6Hypotension (Low Blood Pressure)
11/2020 - 05/2004
6Stroke (Strokes)
01/2019 - 01/2006
5Gout
01/2023 - 06/2002
5Neoplasms (Cancer)
01/2020 - 01/2011
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 08/2006
5Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2011 - 09/2002
4Vascular Calcification
01/2020 - 08/2013
4Overweight
10/2019 - 01/2015
4Left Ventricular Dysfunction
01/2018 - 09/2005
4Fibrosis (Cirrhosis)
12/2015 - 06/2004
4Atherosclerosis
12/2012 - 04/2007
4Myocardial Infarction
01/2011 - 01/2006
3COVID-19
01/2024 - 01/2021
3Inflammation (Inflammations)
01/2023 - 12/2009
3Hypoxia (Hypoxemia)
01/2023 - 06/2002
3Kidney Diseases (Kidney Disease)
03/2022 - 09/2014
3Sleep Apnea Syndromes (Sleep Apnea)
01/2020 - 01/2015
3Proteinuria
01/2020 - 06/2011
3Acute Kidney Injury (Acute Renal Failure)
09/2017 - 02/2009
3Secondary Hyperparathyroidism
01/2015 - 02/2008
2Coronary Disease (Coronary Heart Disease)
11/2023 - 01/2011
2Malnutrition (Nutritional Deficiencies)
01/2023 - 01/2012
2Glycosuria
01/2022 - 06/2018

Drug/Important Bio-Agent (IBA)

38SodiumIBA
01/2023 - 02/2002
36Antihypertensive Agents (Antihypertensives)IBA
03/2024 - 07/2000
21SaltsIBA
01/2022 - 06/2002
12PotassiumIBA
01/2021 - 09/2005
11Uric Acid (Urate)IBA
01/2023 - 06/2002
11AldosteroneIBA
01/2022 - 06/2004
10ReninIBA
04/2017 - 01/2002
9CreatinineIBA
12/2019 - 01/2006
8Hydrochlorothiazide (Esidrix)FDA LinkGeneric
03/2023 - 05/2005
7Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2004
7Angiotensin Receptor AntagonistsIBA
01/2020 - 03/2006
7Insulin (Novolin)FDA Link
01/2020 - 03/2004
6DiureticsIBA
03/2024 - 12/2016
6IrbesartanFDA LinkGeneric
01/2020 - 05/2003
6AngiotensinsIBA
04/2017 - 01/2002
6CalciumIBA
12/2016 - 10/2007
6Pioglitazone (Actos)FDA Link
01/2014 - 03/2004
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2013 - 01/2002
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
03/2024 - 01/2006
5Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2012
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2010
5AlbuminsIBA
01/2018 - 10/2010
5oxidized low density lipoproteinIBA
01/2017 - 01/2007
5Vitamin DFDA LinkGeneric
09/2014 - 09/2007
5Angiotensin IIIBA
05/2011 - 01/2002
4Endothelin Receptor AntagonistsIBA
03/2022 - 03/2012
4SteroidsIBA
01/2022 - 04/2016
4LDL CholesterolIBA
01/2017 - 11/2013
4CholesterolIBA
07/2015 - 03/2010
4lercanidipineIBA
12/2013 - 10/2007
4Desoxycorticosterone Acetate (DOCA)FDA Link
05/2012 - 06/2002
4Losartan (Cozaar)FDA LinkGeneric
06/2011 - 06/2002
4Telmisartan (Micardis)FDA Link
01/2010 - 05/2005
3finerenoneIBA
02/2024 - 03/2022
3Sodium-Glucose Transporter 2 InhibitorsIBA
01/2023 - 06/2018
3LeptinIBA
10/2019 - 01/2010
3Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2019 - 01/2011
3Neprilysin (Neutral Endopeptidase)IBA
01/2019 - 01/2017
3LipidsIBA
01/2017 - 01/2012
3ElectrolytesIBA
02/2016 - 02/2009
3Phosphates (Orthophosphate)IBA
01/2015 - 09/2011
3IronIBA
01/2015 - 12/2008
3HDL CholesterolIBA
01/2014 - 09/2002
31,4-dihydropyridine (dihydropyridine)IBA
12/2013 - 01/2006
3LDL Lipoproteins (beta Lipoproteins)IBA
11/2013 - 01/2007
3MineralocorticoidsIBA
05/2012 - 06/2002
3EnzymesIBA
08/2004 - 09/2002
2Chlorthalidone (Chlortalidone)FDA LinkGeneric
02/2024 - 03/2014
2Mineralocorticoid Receptor AntagonistsIBA
01/2023 - 03/2022
2FebuxostatFDA Link
01/2023 - 01/2019
2Hormones (Hormone)IBA
01/2022 - 04/2016
2GlucocorticoidsIBA
01/2022 - 01/2019
2Blood Glucose (Blood Sugar)IBA
01/2022 - 06/2018

Therapy/Procedure

32Therapeutics
01/2024 - 07/2000
12Denervation
01/2023 - 09/2013
10Renal Dialysis (Hemodialysis)
01/2022 - 01/2007
6Kidney Transplantation
01/2022 - 12/2017
5Drug Therapy (Chemotherapy)
12/2021 - 07/2000
3Peritoneal Dialysis
04/2017 - 01/2017
3Lower Body Negative Pressure
03/2006 - 01/2004
2Renal Replacement Therapy (Therapies, Renal Replacement)
03/2022 - 01/2021